ARCHIVES

Lasagna Committee Report Advocates Faster Drug approval, Insurance Coverage For Investigational Drugs, Ancillary Costs

This article is from The Cancer Letter archive.

Vol. 16 No. 34 | September 7, 1990

Download PDF Visit The Full Archive

Related Articles

ORI Finds St. Mary’s Data Managers Falsified Data In BCPT

September 8, 1995

Learning From Europeans, U.S. Oncologists Consider Role For Oxaliplatin, 5-FU Infusion

May 31, 2002

In Brief: Bishop Named Interim Chairman of NCAB; AACI Elects Wicha president, Herberman VP

December 12, 1997

Also HHS Inspector General is reviewing Lester Crawford’s departure from FDA.

October 28, 2005

NCI Names Brawly Director of Office of Special Populations

June 21, 1996

In Congress: $135 Million Expected For DOD Breast Cancer Research Program

July 24, 1998